Session » (0283–0307) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I
-
Abstract Number: 0283
Transcriptomic Profiles in Muscle Biopsies from Systemic Sclerosis Patients with Different Autoantibodies
-
Abstract Number: 0284
Phenotyping Calcinosis: A Rare Manifestation of Rare Diseases
-
Abstract Number: 0285
Patient Reported Physical Function, Mental Health, and Treatment Patterns in Dermatomyositis
-
Abstract Number: 0286
Relationship Between High Resolution Computed Tomography(HRCT) Quantitative Scores and Physiological and Clinical Features in Antisynthetase Syndrome Related Interstitial Lung Disease
-
Abstract Number: 0287
6-Minute Walk Distance Associates with Physiologic Measures and Physician/Patient Reported Outcomes in Myositis Related Interstitial Lung Disease
-
Abstract Number: 0288
Proinflammatory Bioactive Lipid Mediators (BLM) Are Associated with Worse Anti-Oxidant Function of High Density Lipoproteins (HDL) in Patients with Idiopathic Inflammatory Myopathies (IIM)
-
Abstract Number: 0289
Markers of Endothelial Damage Are Elevated in Patients with Dermatomyositis Associated Interstitial Lung Disease and Associated with Low Paraoxonase-1 Activity
-
Abstract Number: 0290
Patient-reported Quality of Life and Working Status Outcomes in Ambulatory Patients with Idiopathic Inflammatory Myopathy
-
Abstract Number: 0291
Myopathy Related to Small-to-medium-sized Vessel Vasculitis: Immunopathological Characteristics
-
Abstract Number: 0292
Comparison of Cardiovascular Risk of Myositis Patients and the General Population
-
Abstract Number: 0293
Characteristics and Outcomes of Idiopathic Inflammatory Myositis Associated Interstitial Lung Disease in Rural Appalachia
-
Abstract Number: 0294
Tofacitinib Treatment in Rheumatoid Arthritis Is Associated with Increased Lower Limb Muscle Volume: The Rheumatoid Arthritis and Muscle (RAMUS) Study
-
Abstract Number: 0295
Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Myopathies
-
Abstract Number: 0296
Does Presence of Anti-SSa and Ro52 Influence the Progression of Interstitial Lung Disease (ILD) in Idiopathic Inflammatory Myopathies (IIM)
-
Abstract Number: 0297
Characteristics of Anti-MDA-5 Associated Dermatomyositis in Southern California with a Large Hispanic Population: Case Series
-
Abstract Number: 0299
Trends and Outcomes of Hospitalized Patients with Idiopathic Inflammatory Myopathy and Venous Thromboembolism: A Nationwide Inpatient Sample Analysis from US (2016-2019)
-
Abstract Number: 0300
Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathy Compared with Healthy Controls
-
Abstract Number: 0301
Inflammatory Myopathies and Their Relationship with Cancer in a Colombian Cohort
-
Abstract Number: 0302
Remission in Anti-HMGCR Positive Immune-mediated Necrotizing Myopathy Without the Use of Glucocorticoids: A Multicentric Study of 24 Patients
-
Abstract Number: 0303
Development of a Human Cytotoxic Myoinjury Model with CD8+ T Cells and Muscle Cells Differentiated from Human Induced Pluripotent Stem Cells
-
Abstract Number: 0304
Incidence of Disease Flares Following COVID-19 Vaccination in a Diverse Idiopathic Inflammatory Myopathy Cohort
-
Abstract Number: 0305
Prevalence and Clinical Significance of anti-Ro52 Antibodies in Antisynthetase Syndrome
-
Abstract Number: 0306
Fitbit Is a Valid and Reliable Physical Activity Monitor in Idiopathic Inflammatory Myopathy
-
Abstract Number: 0307
Long-term Prognosis and Recurrence in anti-MDA-5 Antibody-positive Dermatomyositis